Bengaluru based startup, Axio Biosolutions has launched RESIST+, a hygiene and protection range to meet the growing demand due to the current pandemic.

Funded by Ratan Tata’s UC RNT, Omidyar Network and other investors, the startup has rolled out surgical hand disinfectants and hand sanitizers with a running capacity of 25,000 litres at present. The plan is to expand the capacity to 100,000 litres in the coming days.

The new product range, manufactured in compliance with WHO standards and Pharma regulations, will soon include masks and other protective gear.

Commenting on the rationale behind RESIST+, Leo Mavely, Founder & CEO, Axio Biosolutions, said, “For India to tackle the pandemic, we need to address the large-scale shortage of quality hygiene and safety products. Hospitals are getting overwhelmed with deluge of patients and the dearth of quality products is a challenge. People are forced to procure sanitizers and disinfectants from various unvetted non-medical sources. The need of the hour is for medtech companies is to support in every way they can. At Axio, our priority is to meet the urgent demands from hospitals and institutions in India, followed by other regions."

This may also become a permanent consumer product line with more innovative hygiene products with proprietary formula to be added under the brand RESIST+ 

Resist + hand sanitizer contains 70 per cent alcohol, while Resist + surgical hand disinfectant contains 75 per cent alcohol.

Currently Axio is ramping up their supply chain during the lockdown with support from local government to get their products to major cities.